Report cover image

Hysteroscopic Tissue Removal Market by Procedure Type (Adhesiolysis, Endometrial Ablation, Hysteroscopic Myomectomy), System (Anesthesia & Monitoring Systems, Electrosurgical System, Fluid Management System), End-User - Global Forecast 2024-2030

Publisher 360iResearch
Published Jan 15, 2024
Length 188 Pages
SKU # IRE18444699

Description

Hysteroscopic Tissue Removal Market by Procedure Type (Adhesiolysis, Endometrial Ablation, Hysteroscopic Myomectomy), System (Anesthesia & Monitoring Systems, Electrosurgical System, Fluid Management System), End-User - Global Forecast 2024-2030


The Hysteroscopic Tissue Removal Market size was estimated at USD 4.30 billion in 2023 and expected to reach USD 4.71 billion in 2024, at a CAGR 9.13% to reach USD 7.93 billion by 2030.

Global Hysteroscopic Tissue Removal Market

FPNV Positioning Matrix

The FPNV Positioning Matrix is pivotal in evaluating the Hysteroscopic Tissue Removal Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Hysteroscopic Tissue Removal Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Key Company Profiles

The report delves into recent significant developments in the Hysteroscopic Tissue Removal Market, highlighting leading vendors and their innovative profiles. These include Aveta by Meditrina, Inc., B. Braun SE, Boston Scientific Corporation, Channel Medsystems Inc., Cook Group Incorporated, CooperSurgical Inc., Cytomed by LeukoSite Inc., GenWorks Health Pvt. Ltd., Gynesonics, Inc., Hologic, Inc., KARL STORZ SE & Co. KG, LiNA Medical ApS, MedGyn Products, Inc., Medtronic PLC, Minerva Surgical, Inc., Normedi Nordic AS, Olympus Corporation, Richard Wolf GmbH, Schultz Medical, Stryker Corporation, and VirtaMed AG.

Market Segmentation & Coverage

This research report categorizes the Hysteroscopic Tissue Removal Market to forecast the revenues and analyze trends in each of the following sub-markets:

Procedure Type
Adhesiolysis

Endometrial Ablation

Hysteroscopic Myomectomy

Polypectomy

Tubal Sterilization

Uterine Septum Resection

System
Anesthesia & Monitoring Systems

Electrosurgical System

Fluid Management System

Hysteroscope System

Instrumentation
Hand-Held Instruments

Hysteroscopes

Resectoscopes

End-User
Ambulatory Surgery Centers (ASCs)

Hospitals & Clinics

Region
Americas
Argentina

Brazil

Canada

Mexico

United States
California

Florida

Illinois

New York

Ohio

Pennsylvania

Texas

Asia-Pacific
Australia

China

India

Indonesia

Japan

Malaysia

Philippines

Singapore

South Korea

Taiwan

Thailand

Vietnam

Europe, Middle East & Africa
Denmark

Egypt

Finland

France

Germany

Israel

Italy

Netherlands

Nigeria

Norway

Poland

Qatar

Russia

Saudi Arabia

South Africa

Spain

Sweden

Switzerland

Turkey

United Arab Emirates

United Kingdom

The report offers valuable insights on the following aspects:

1. Market Penetration: It presents comprehensive information on the market provided by key players.
2. Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.
3. Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.
4. Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.
5. Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.

The report addresses key questions such as:

1. What is the market size and forecast of the Hysteroscopic Tissue Removal Market?
2. Which products, segments, applications, and areas should one consider investing in over the forecast period in the Hysteroscopic Tissue Removal Market?
3. What are the technology trends and regulatory frameworks in the Hysteroscopic Tissue Removal Market?
4. What is the market share of the leading vendors in the Hysteroscopic Tissue Removal Market?
5. Which modes and strategic moves are suitable for entering the Hysteroscopic Tissue Removal Market?

Note: PDF & Excel + Online Access - 1 Year

Table of Contents

188 Pages
1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Hysteroscopic Tissue Removal Market, by Region
5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Increasing awareness of diagnosis and treatment of gynecological and structural intrauterine abnormalities
5.1.1.2. Growing patient inclination toward minimally invasive surgeries worldwide
5.1.2. Restraints
5.1.2.1. High costs and less awareness of hysteroscopic tissue removal surgeries
5.1.3. Opportunities
5.1.3.1. Supportive governmental approval procedures for hysteroscopic tissue removal systems
5.1.3.2. Advancements and development of novel product portfolios for better patient outcome
5.1.4. Challenges
5.1.4.1. Complications associated with hysteroscopic surgeries
5.2. Market Segmentation Analysis
5.3. Market Trend Analysis
5.4. Cumulative Impact of High Inflation
5.5. Porter’s Five Forces Analysis
5.5.1. Threat of New Entrants
5.5.2. Threat of Substitutes
5.5.3. Bargaining Power of Customers
5.5.4. Bargaining Power of Suppliers
5.5.5. Industry Rivalry
5.6. Value Chain & Critical Path Analysis
5.7. Regulatory Framework
6. Hysteroscopic Tissue Removal Market, by Procedure Type
6.1. Introduction
6.2. Adhesiolysis
6.3. Endometrial Ablation
6.4. Hysteroscopic Myomectomy
6.5. Polypectomy
6.6. Tubal Sterilization
6.7. Uterine Septum Resection
7. Hysteroscopic Tissue Removal Market, by System
7.1. Introduction
7.2. Anesthesia & Monitoring Systems
7.3. Electrosurgical System
7.4. Fluid Management System
7.5. Hysteroscope System
7.6. Instrumentation
7.7.1. Hand-Held Instruments
7.7.2. Hysteroscopes
7.7.3. Resectoscopes
8. Hysteroscopic Tissue Removal Market, by End-User
8.1. Introduction
8.2. Ambulatory Surgery Centers (ASCs)
8.3. Hospitals & Clinics
9. Americas Hysteroscopic Tissue Removal Market
9.1. Introduction
9.2. Argentina
9.3. Brazil
9.4. Canada
9.5. Mexico
9.6. United States
10. Asia-Pacific Hysteroscopic Tissue Removal Market
10.1. Introduction
10.2. Australia
10.3. China
10.4. India
10.5. Indonesia
10.6. Japan
10.7. Malaysia
10.8. Philippines
10.9. Singapore
10.
10. South Korea
10.
11. Taiwan
10.
12. Thailand
10.
13. Vietnam
11. Europe, Middle East & Africa Hysteroscopic Tissue Removal Market
11.1. Introduction
11.2. Denmark
11.3. Egypt
11.4. Finland
11.5. France
11.6. Germany
11.7. Israel
11.8. Italy
11.9. Netherlands
11.
10. Nigeria
11.
11. Norway
11.
12. Poland
11.
13. Qatar
11.
14. Russia
11.
15. Saudi Arabia
11.
16. South Africa
11.
17. Spain
11.
18. Sweden
11.
19. Switzerland
11.
20. Turkey
11.
21. United Arab Emirates
11.
22. United Kingdom
12. Competitive Landscape
12.1. FPNV Positioning Matrix
12.2. Market Share Analysis, By Key Player
12.3. Competitive Scenario Analysis, By Key Player
13. Competitive Portfolio
13.1. Key Company Profiles
13.1.1. Aveta by Meditrina, Inc.
13.1.2. B. Braun SE
13.1.3. Boston Scientific Corporation
13.1.4. Channel Medsystems Inc.
13.1.5. Cook Group Incorporated
13.1.6. CooperSurgical Inc.
13.1.7. Cytomed by LeukoSite Inc.
13.1.8. GenWorks Health Pvt. Ltd.
13.1.9. Gynesonics, Inc.
13.1.
10. Hologic, Inc.
13.1.
11. KARL STORZ SE & Co. KG
13.1.
12. LiNA Medical ApS
13.1.
13. MedGyn Products, Inc.
13.1.
14. Medtronic PLC
13.1.
15. Minerva Surgical, Inc.
13.1.
16. Normedi Nordic AS
13.1.
17. Olympus Corporation
13.1.
18. Richard Wolf GmbH
13.1.
19. Schultz Medical
13.1.
20. Stryker Corporation
13.1.
21. VirtaMed AG
13.2. Key Product Portfolio
14. Appendix
14.1. Discussion Guide
14.2. License & Pricing
FIGURE 1. HYSTEROSCOPIC TISSUE REMOVAL MARKET RESEARCH PROCESS
FIGURE 2. HYSTEROSCOPIC TISSUE REMOVAL MARKET SIZE, 2023 VS 2030
FIGURE 3. HYSTEROSCOPIC TISSUE REMOVAL MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 4. HYSTEROSCOPIC TISSUE REMOVAL MARKET SIZE, BY REGION, 2023 VS 2030 (%)
FIGURE 5. HYSTEROSCOPIC TISSUE REMOVAL MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 6. HYSTEROSCOPIC TISSUE REMOVAL MARKET DYNAMICS
FIGURE 7. HYSTEROSCOPIC TISSUE REMOVAL MARKET SIZE, BY PROCEDURE TYPE, 2023 VS 2030 (%)
FIGURE 8. HYSTEROSCOPIC TISSUE REMOVAL MARKET SIZE, BY PROCEDURE TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 9. HYSTEROSCOPIC TISSUE REMOVAL MARKET SIZE, BY SYSTEM, 2023 VS 2030 (%)
FIGURE 10. HYSTEROSCOPIC TISSUE REMOVAL MARKET SIZE, BY SYSTEM, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 11. HYSTEROSCOPIC TISSUE REMOVAL MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
FIGURE 12. HYSTEROSCOPIC TISSUE REMOVAL MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 13. AMERICAS HYSTEROSCOPIC TISSUE REMOVAL MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 14. AMERICAS HYSTEROSCOPIC TISSUE REMOVAL MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 15. UNITED STATES HYSTEROSCOPIC TISSUE REMOVAL MARKET SIZE, BY STATE, 2023 VS 2030 (%)
FIGURE 16. UNITED STATES HYSTEROSCOPIC TISSUE REMOVAL MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 17. ASIA-PACIFIC HYSTEROSCOPIC TISSUE REMOVAL MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 18. ASIA-PACIFIC HYSTEROSCOPIC TISSUE REMOVAL MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 19. EUROPE, MIDDLE EAST & AFRICA HYSTEROSCOPIC TISSUE REMOVAL MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 20. EUROPE, MIDDLE EAST & AFRICA HYSTEROSCOPIC TISSUE REMOVAL MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 21. HYSTEROSCOPIC TISSUE REMOVAL MARKET, FPNV POSITIONING MATRIX, 2023
FIGURE 22. HYSTEROSCOPIC TISSUE REMOVAL MARKET SHARE, BY KEY PLAYER, 2023

Pricing

Currency Rates
How Do Licenses Work?

How Do Licenses Work?

The primary function of a report license is to define how many people within a company are authorized to use the purchased report. This is separate to how a report might be delivered. Unless specifically identified otherwise, the purchase option is Single User. Below is a helpful description of that license, along with a sampling of others most commonly offered.

  • This license allows only one user to have access to and to use/read the report. It is not one user at a time or one user group; it is an individual who will be reading and utilizing the report.

  • This license allows for the entire purchasing company to read and use the report. This is the license level that would allow for a report to be placed on an internal company shared drive for access by all employees of that direct company. This license does not extend to parent or sister company use.

  • This license is designed to allow an entire department within a company full access to a report. The departmental license is a great option for companies that have more than one location and the department is spread out all over the country/world

  • This license is for companies that have one location where they want the report to be accessible by all employees within that physical location.

  • This is the most flexible of the licensing options. Some publishers will allow you to get a license for a preset number of people (typically 5). These licenses are ideal for small work groups.

License options are at the discretion of each publisher. As such, not all licenses indicated above are available for every product. If you are uncertain of the best license for your needs or would like a license that is not proactively available, please contact us and we will be happy to assist.

Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
Chat Now
Contact Us